The U.S. Food and Drug Administration’s approval of Viz.ai’s hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software.
WHY IT MATTERS
Viz.ai, a disease detection and intelligent care coordination company, said in its announcement…
Source: Healthcareitnews.com and Read More
Report: Cyber security a unique challenge for the healthcare sector
The Australian healthcare sector is increasingly targeted by cyber criminals, with a rise in ransomware attacks, according to a report by CyberCX. Non-hospital providers are
